Rxsight
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $45,408 | $34,887 | $29,512 | $28,580 |
Gross Profit | 25,220 | 24,250 | 20,685 | 17,654 |
EBITDA | -5,179 | -5,237 | -7,945 | -8,107 |
EBIT | -6,320 | -6,057 | -9,085 | -9,191 |
Net Income | -6,338 | -6,079 | -9,100 | -9,177 |
Net Change In Cash | 45,408 | 34,887 | 29,512 | 28,580 |
Free Cash Flow | -453 | -5,630 | -11,276 | -11,480 |
Cash | 16,720 | 24,445 | 32,645 | 9,692 |
Basic Shares | 39,788 | 38,455 | 36,843 | 35,961 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $89,077 | $49,005 | $22,593 | $14,678 |
Gross Profit | 53,765 | 21,328 | 4,517 | 1,705 |
EBITDA | -41,037 | -57,779 | -41,010 | 32,154 |
EBIT | -45,280 | -61,801 | -44,998 | 28,142 |
Net Income | -48,608 | -66,756 | -48,688 | 27,575 |
Net Change In Cash | 89,077 | 49,005 | 22,593 | 14,678 |
Cost of Revenue | -12,568 | 10,727 | ||
Free Cash Flow | -46,407 | -61,243 | -46,648 | -37,742 |
Cash | 9,692 | 11,834 | 24,361 | 13,994 |
Basic Shares | 34,455 | 27,661 | 27,366 | 27,623 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.16 |
2024-06-30 | -$0.16 |
2024-03-31 | -$0.25 |
2023-12-31 | -$0.26 |
